JavaScript is NOT enabled !

Please enable JavaScript.

Article

PubMed

This record comes from PubMed

Re: Gemcitabine and Cisplatin plus Nivolumab as Organ-sparing Treatment for Muscle-invasive Bladder Cancer: A Phase 2 Trial. Galsky MD, Daneshmand S, Izadmehr S, et al. Nat Med 2023;29:2825-34

Shariat, Shahrokh F
Author Shariat, Shahrokh F Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: shahrokh.shariat@meduniwien.ac.at
Laukhtina, Ekaterina
Author Laukhtina, Ekaterina Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia

European urology. 2024 May ; 85 (5) : 501-502. [epub] 20240215

Eur Urol
ISSN 1873-7560 | 0302-2838
Source

Language English Country Switzerland Media print-electronic

Document type Clinical Trial, Phase II, Journal Article

Persistent link https://www.medvik.cz/link/pmid38360442

PubMed 38360442
DOI 10.1016/j.eururo.2024.01.024
PII: S0302-2838(24)00066-6
Knihovny.cz E-resources

MeSH
Cisplatin therapeutic use MeSH
Gemcitabine * MeSH
Humans MeSH
Urinary Bladder Neoplasms * drug therapy MeSH
Neoadjuvant Therapy MeSH
Nivolumab therapeutic use MeSH
Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
Muscles MeSH
Check Tag
Humans MeSH
Publication type
Journal Article MeSH
Clinical Trial, Phase II MeSH
Names of Substances
Cisplatin MeSH
Gemcitabine * MeSH
Nivolumab MeSH

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria; Institute for Urology and Reproductive Health Sechenov University Moscow Russia

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria; Institute for Urology and Reproductive Health Sechenov University Moscow Russia; Karl Landsteiner Institute of Urology and Andrology Vienna Austria; Department of Urology Weill Cornell Medical College New York NY USA; Department of Urology University of Texas Southwestern Dallas TX USA; Department of Urology 2nd Faculty of Medicine Charles University Prague Czechia; Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan

References provided by Crossref.org

Borrow
RIS

Find record

In BMC

Citation metrics